Lista de obras - Samuli Eldfors - Dominio Público Uruguay

3Precision systems medicine in urological Tumors – Molecular profiling and functional testing

A6.02 Somatic mutations in clonally expanded CD8+T cells in patients with newly diagnosed rheumatoid arthritis

scholarly article by Tiina Kelkka et al published February 2016 in Annals of the Rheumatic Diseases

Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia

artículo científico publicado en 2015

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.

artículo científico publicado en 2018

Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.

artículo científico publicado en 2014

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells

scientific article published on 04 November 2018

Comparison of solution-based exome capture methods for next generation sequencing

artículo científico publicado en 2011

Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer

artículo científico publicado en 2016

Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas

artículo científico publicado en 2018

Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia

scientific article published on 19 December 2018

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

artículo científico publicado en 2017

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

artículo científico publicado en 2013

Does breast carcinoma belong to the Lynch syndrome tumor spectrum? - Somatic mutational profiles vs. ovarian and colorectal carcinomas

scientific article published on 07 April 2020

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML

artículo científico publicado en 2016

Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based study

scientific article published on 07 January 2019

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.

artículo científico publicado en 2016

High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.

artículo científico publicado en 2016

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

artículo científico publicado en 2016

Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

artículo científico publicado en 2017

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

artículo científico publicado en 2013

Molecular Basis of Mismatch Repair Protein Deficiency in Tumors from Lynch Suspected Cases with Negative Germline Test Results

artículo científico publicado en 2020

Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia

artículo científico publicado en 2016

Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia

artículo científico publicado en 2020

Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencing

artículo científico publicado en 2014

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

artículo científico publicado en 2014

Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation

artículo científico publicado en 2013

Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers.

artículo científico publicado en 2016

Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations

artículo científico publicado en 2017

Somatic STAT3 mutations in large granular lymphocytic leukemia ⬇️

artículo científico publicado en 2012

Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease

scientific article published on 07 May 2020

Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis.

artículo científico publicado en 2017

Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer

artículo científico publicado en 2016

Lista de obras de Samuli Eldfors

3Precision systems medicine in urological Tumors – Molecular profiling and functional testing

A6.02 Somatic mutations in clonally expanded CD8+T cells in patients with newly diagnosed rheumatoid arthritis

Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.

Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells

Comparison of solution-based exome capture methods for next generation sequencing

Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer

Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas

Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

Does breast carcinoma belong to the Lynch syndrome tumor spectrum? - Somatic mutational profiles vs. ovarian and colorectal carcinomas

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML

Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based study

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.

High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Molecular Basis of Mismatch Repair Protein Deficiency in Tumors from Lynch Suspected Cases with Negative Germline Test Results

Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia

Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia

Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencing

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation

Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers.

Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations

Somatic STAT3 mutations in large granular lymphocytic leukemia ⬇️

Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease

Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis.

Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer